Caregiver Outcomes of Alzheimer's Disease Screening (COADS)
Alzheimer Disease
About this trial
This is an interventional screening trial for Alzheimer Disease
Eligibility Criteria
Inclusion Criteria:
Patients
- 65 years or older
- At least one visit to primary care practice within past 24 months
- Ability to provide informed consent
- Ability to communicate in English
Family Members
- 21 years or older
- Identified by the patient as the person most likely to provide them care if needed.*
- Lives with the patient or lives within a 50 mile radius.
- Ability to provide informed consent.
- Ability to communicate in English
Exclusion Criteria:
Patients
- Has a diagnosis of AD as determined by ICD-10 code.
- Evidence of a prescription for a cholinesterase inhibitors or memantine.
- Has serious mental illness such as bipolar or schizophrenia as determined by ICD-10 code
- Permanent resident of a nursing facility
- Already seen by the Healthy Aging Brain Care Program
Family Member
- Is a non-family member who is not a legal Healthcare Power of Attorney
- Has serious mental illness such as bipolar or schizophrenia as determined by ICD-10 code
- Has a diagnosis of AD as determined by ICD-10 code.
Sites / Locations
- Eskenazi Hospital
- IU Health-Primary Care Clinics
Arms of the Study
Arm 1
Arm 2
Arm 3
No Intervention
Active Comparator
Experimental
Control
Screening Only
Collaborative Dementia Care Program
The patients in this group will receive no AD screening
The patients in this group will receive screening for AD. Patients and family members will receive a letter about how the patient performed on the screening. If they screen positive (e.g. ≤5 on the MIS-T or ≤2 on the Mini-Cog), the patient and family member will receive an infographic and some information about local clinical resources for them to peruse regarding follow-up care. The patient's PCP is also be notified of the screening results via EHR message.
The patients in this group will receive screening for AD, Patients and family members will receive a letter about how the patient performed on the screening. If they screen positive (e.g. ≤5 on the MIS-T or ≤2 on the Mini-Cog), the patient and family member will receive an infographic. Also, the family member will receive two follow-up phone calls. One from the COADS Study Coordinator and one from a care coordinator at the Aging Brain Care Program (ABC). This phone call will include an opportunity for the family to ask questions and a conversation about the program and diagnostic evaluation and management. Dyads have the option to refuse the follow-up visit. The patient's PCP is also be notified of the screening results via EHR message,